caimagen

Revista de Medicina Interna. AMICAC.

Volver

Año VII. 2015 No.5

Mes Mayo 2015

Iron deficiency and iron-deficiency anemia are global health
problems and common medical conditions seen in everyday clinical practice. Although the prevalence of iron-deficiency anemia has recently declined somewhat, iron deficiency continues to be the top-ranking cause of anemia worldwide, and iron-deficiency anemia has a substantial effect on the lives of............

SGLT2 Inhibitor Diabetes Drugs May Cause Ketoacidosis: FDA
Megan Brooks.

The US Food and Drug Administration (FDA) warned today that sodium-glucose cotransporter-2 (SGLT2) inhibitors used to treat type 2 diabetes may lead to ketoacidosis requiring hospitalization..............

Metoclopramide and Diphenhydramine Blunt Pregnancy Headaches
Laird Harrison.

SAN FRANCISCO — Intravenous metoclopramide plus diphenhydramine is a more effective way to reduce headaches in pregnant women than codeine and is worth the extra cost, new research shows. Results from the study support the use of this regimen to "break the cycle of headache pain," said Katherine Scolari Childress, MD, from Saint Louis.........
Abuse Risk Evaluation Changes Opioid Prescribing
Laird Harrison. May 15, 2015

PALM SPRINGS, California — Physicians would prescribe opioids less often to patients at high risk for abuse if they had information that could help them identify these patients, a new study shows."It seemed to help simplify the decision making process," said Alison Vargovich, PhD, from the Cleveland Clinic in Ohio...........

Prions, the Pipeline, and the Latest in Parkinson Disease. Bret S. Stetka, MD, Maurizio Facheris, MD, MSc
Two Fridays ago, the news was released that Adamas Pharmaceuticals received orphan drug status by the US Food and Drug Administration (FDA) for extended-release amantadine, a drug they're developing to treat levodopa-induced dyskinesia in patients with PD. I truly think this is great news and will help speed up development of.....

Obesity as a "Brain Disease"; a Driver for New Therapies
Lisa Nainggolan

PRAGUE — Obesity is a complex multifactorial disease that acts as a gateway to many other chronic conditions — with resultant enormous impact — and should actually be viewed as a brain disease, one expert argues.
Speaking at the 2015 European Congress on Obesity today, bariatric surgeon Carel Le Roux, MBChB, PhD, of University College Dublin, Ireland, explained

 

 

 

 

 

 

 

 

amicac1